MYC dysregulation in the progression of multiple myeloma

por Misund, K, Keane, N, Stein, CK, Asmann, YW, Day, G, Welsh, S, Wier, SV, Riggs, D, Ahmann, G, Chesi, M, Viswanatha, D, Kumar, SK, Dispenzieri, A, Gonzalez-Calle, V, Kyle, RA, O’Dwyer, M, Rajkumar, SV, Kortüm, KM, Keats, J, Fonseca, R, Stewart, AK, Kuehl, WM, Braggio, E, Bergsagel, PL
Publicado 2019

P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR T-CELL THERAPY

por Ortiz De Landazuri, I., Oliver-Caldés, A., Español-Rego, M., Contreras, M. T., Zabaleta, A., Agulló, C., Puig, N., Cabañas, V., González-Calle, V., Jiménez, R., Inogés, S., Rodríguez-Otero, P., Martin-Antonio, B., Reguera, J. L., López-Diaz de Cerio, A., Benítez-Ribas, D., Rodríguez-Lobato, L. G., González, E. A., Rosiñol, L., Yagüe, J., Moraleda, J. M., Urbano-Ispizua, Á., Mateos, M. V., Juan, M., Paiva, B., Pascal, M., Fernández de Larrea, C.
Publicado 2022